Watson Laboratories, Inc. Sustainability Profile
Watson Laboratories, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 1984, the company has established itself as a leader in the development and manufacturing of generic and branded medications, primarily focusing on therapeutic areas such as dermatology, women's health, and urology. With a commitment to quality and innovation, Watson Laboratories offers a diverse portfolio of products, including oral and topical formulations that cater to the evolving needs of healthcare providers and patients. The company has achieved significant milestones, including strategic acquisitions that have expanded its market presence and product offerings. Recognised for its dedication to excellence, Watson Laboratories continues to strengthen its position in the competitive pharmaceutical landscape, making strides in both domestic and international markets.
DitchCarbon Score
How does Watson Laboratories, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Watson Laboratories, Inc.'s score of 82 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Watson Laboratories, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Teva Pharmaceutical Industries Limited, which means that any climate commitments or emissions data may be inherited from its parent organisation. Teva Pharmaceutical Industries Limited has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Watson Laboratories, Inc. have not been detailed in the available information. As a subsidiary, Watson Laboratories may align its climate strategies with those of Teva, which is committed to reducing its carbon footprint and enhancing sustainability practices across its operations. The lack of direct emissions data suggests that Watson Laboratories is still in the process of developing its own specific climate commitments or may rely on the overarching strategies of its parent company. In summary, while Watson Laboratories, Inc. does not currently provide specific emissions data or reduction targets, it is positioned within a corporate structure that prioritises climate action through its parent company, Teva Pharmaceutical Industries Limited.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 438,420,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 613,541,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Watson Laboratories, Inc.'s Industry?
How Carbon Intensive is Watson Laboratories, Inc.'s Location?
Watson Laboratories, Inc.'s Scope 3 Categories Breakdown
Watson Laboratories, Inc.'s Scope 3 emissions, which decreased by 6% last year and decreased by approximately 24% since 2020, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 61% of Scope 3 emissions.
Top Scope 3 Categories
Watson Laboratories, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Watson Laboratories, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
